Antihistamine shows promise for treating rare genetic liver disease

A common antihistamine may offer hope for patients with a rare genetic disease that can lead to severe liver damage and ultimately require transplantation, according to new research from Rutgers Health.

Opinion | The ‘Best We Have’ Isn’t Working for Endometriosis Patients

Metz is a professor of medical research and the head of a medicinal biochemistry lab. The pain of endometriosis — chronic, severe, and deep —

March 20, 2024

Medicare should wait on approving coverage for new obesity drugs

My dad, Randy, a 72-year-old retired sales manager, started to gain weight after grad school, and it didn’t let up until he was middle-aged. He’s

July 1, 2024

Improving the FDA-EMA parallel scientific advice program to advance complex generics

Off-patent medicines provide people with access to high-quality essential treatment options that can be significantly less expensive than branded on-patent medicines. Off-patent therapies — generics

August 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.